- Lobbying
- Lobbying by United States Pharmacopeial Convention
Lobbying Relationship
Bills mentioned
H.R.2871: Preserving Patient Access to Compounded Medications Act of 2017
Sponsor: Morgan Griffith (R-Va.)
S.2700: FDA and NIH Workforce Authorities Modernization Act
Sponsor: Lamar Alexander (R-Tenn.)
S.1895: Lower Health Care Costs Act
Sponsor: Lamar Alexander (R-Tenn.)
S.3548: CARES Act
Sponsor: Mitch McConnell (R-Ky.)
H.R.748: CARES Act
Sponsor: Joe Courtney (D-Conn.)
H.R.6800: The Heroes Act
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.4866: National Centers of Excellence in Continuous Pharmaceutical...
Sponsor: Frank Pallone (D-N.J.)
H.R.133: Consolidated Appropriations Act, 2021
Sponsor: Henry Cuellar (D-Texas)
H.R.133: David’s Law
Sponsor: Sheila Jackson Lee (D-Texas)
S.2333: Pandemic and All-Hazards Preparedness and Response Act
Sponsor: Bob Casey (D-Pa.)
H.R.4421: Preparing for All Hazards and Pathogens Reauthorization Act
Sponsor: Richard Hudson (R-N.C.)
S.2364: MAPS Act
Sponsor: Gary Peters (D-Mich.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Nate Brown | Hlth pol advsr, Chrmn Harkin, Sen comm on Hlth Ed Lbr & Pnsns, Mar 2013 - Apr 3, 2014. |
Heide Bajnrauh | Intrn, Sen McCain, 94-96; LSA, 96-97. |
Todd Tuten | Rep Michael Bilirakis; 91-92, 93-95, 98-01 |
Anna Abram | Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06 |
Sean Feely | n/a |
Mario Ramirez | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Pharmacy
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Pharmacy
U.S. House of Representatives
Pharmacy
U.S. House of Representatives
Pharmacy
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Pharmacy
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Pharmacy
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Pharmacy
U.S. House of Representatives
Pharmacy
U.S. House of Representatives
Pharmacy
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate